These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11195420)

  • 1. Oncology legislative update.
    Holmes H
    Oncology (Williston Park); 2000 Nov; 14(11A):62-5. PubMed ID: 11195420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncology legislative update.
    Holmes H
    Oncology (Williston Park); 1998 Nov; 12(11A):361-3. PubMed ID: 10028518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anticipated and unintended consequences of the patient protection and affordable care act on cancer research.
    Edge SB; Zwelling LA; Hohn DC
    Cancer J; 2010; 16(6):606-13. PubMed ID: 21131793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new federal medical-privacy rule.
    Kulynych J; Korn D
    N Engl J Med; 2002 Oct; 347(15):1133-4. PubMed ID: 12374872
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Gralow J; Ozols RF; Bajorin DF; Cheson BD; Sandler HM; Winer EP; Bonner J; Demetri GD; Curran W; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Ramsey S; Reaman GH; Sawaya R; Schuchter LM; Sweetenham JW; Vahdat LT; Davidson NE; Schilsky RL; Lichter AS;
    J Clin Oncol; 2008 Jan; 26(2):313-25. PubMed ID: 18086794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
    McCaskill-Stevens W; McKinney MM; Whitman CG; Minasian LM
    J Clin Oncol; 2005 Aug; 23(22):5247-54. PubMed ID: 16051967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concerning trends and outcomes for National Institutes of Health funding of cancer research.
    Bland KI
    J Surg Oncol; 2007 Feb; 95(2):161-6. PubMed ID: 17262723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
    J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating per patient funding for cancer clinical trials: an Ontario based survey.
    Wright JR; Roche K; Smuck B; Cormier J; Cecchetto S; Akow M; Pilatzke S; Pritchard KI
    Contemp Clin Trials; 2005 Aug; 26(4):421-9. PubMed ID: 15925548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory barriers to clinical trial enrollment of adolescent and young adult oncology patients.
    Felgenhauer J; Hooke MC
    Pediatrics; 2014 Jun; 133 Suppl 3():S119-22. PubMed ID: 24918210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Huriet's law in cancerology. Ethical commissions and medical research in Switzerland].
    Alberto P
    Bull Cancer; 1993 Oct; 80(10):890-1. PubMed ID: 8204928
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of progression-free survival as a surrogate marker in oncology trials: some regulatory issues.
    Chakravarty A; Sridhara R
    Stat Methods Med Res; 2008 Oct; 17(5):515-8. PubMed ID: 18285437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the privacy rule on cancer research: variations in attitudes and application of regulatory standards.
    Goss E; Link MP; Bruinooge SS; Lawrence TS; Tepper JE; Runowicz CD; Schilsky RL
    J Clin Oncol; 2009 Aug; 27(24):4014-20. PubMed ID: 19620480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Funding patient-reported outcomes in cancer clinical trials.
    Moinpour CM; Denicoff AM; Bruner DW; Kornblith AB; Land SR; O'Mara A; Trimble E
    J Clin Oncol; 2007 Nov; 25(32):5100-5. PubMed ID: 17991928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The personal data act, clinical trials and data privacy. Rules for treatment of personal data in clinical trials and scientific research projects].
    Daasnes C
    Ugeskr Laeger; 2003 Apr; 165(16):1683-5. PubMed ID: 12756831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Organisation for Research and Treatment of Cancer's point of view.
    Meunier F; Lacombe D
    Lancet; 2003 Aug; 362(9384):663. PubMed ID: 12944069
    [No Abstract]   [Full Text] [Related]  

  • 18. Legislative update.
    AIDS Policy Law; 1999 May; 14(9):8. PubMed ID: 11366969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Working Group of Dermatologic Oncology (ADO)].
    Spieth K
    J Dtsch Dermatol Ges; 2009 Jan; 7(1):89. PubMed ID: 19138302
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program.
    Buchanan DR; O'Mara AM; Kelaghan JW; Minasian LM
    J Clin Oncol; 2005 Jan; 23(3):591-8. PubMed ID: 15659506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.